CHINA BIOLOGIC PRODS HLDGS I's ticker is CBPO and the CUSIP is G21515104. A total of 90 filers reported holding CHINA BIOLOGIC PRODS HLDGS I in Q4 2020. The put-call ratio across all filers is 0.13 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $913,000 | +3.5% | 8,218 | -4.7% | 0.00% | -50.0% |
| Q2 2020 | $882,000 | -12.9% | 8,627 | -8.1% | 0.00% | 0.0% |
| Q1 2020 | $1,013,000 | +40.1% | 9,384 | +51.0% | 0.00% | +100.0% |
| Q4 2019 | $723,000 | -9.7% | 6,216 | -11.2% | 0.00% | -50.0% |
| Q3 2019 | $801,000 | +9.9% | 6,999 | -8.5% | 0.00% | +100.0% |
| Q2 2019 | $729,000 | -12.9% | 7,648 | -16.7% | 0.00% | -50.0% |
| Q1 2019 | $837,000 | -9.8% | 9,178 | -25.0% | 0.00% | 0.0% |
| Q4 2018 | $928,000 | -60.7% | 12,231 | -58.5% | 0.00% | -50.0% |
| Q3 2018 | $2,359,000 | -26.6% | 29,483 | -8.8% | 0.00% | -42.9% |
| Q2 2018 | $3,213,000 | +34.8% | 32,344 | +6.9% | 0.01% | +16.7% |
| Q4 2017 | $2,383,000 | +37.3% | 30,251 | +60.8% | 0.01% | +50.0% |
| Q3 2017 | $1,736,000 | – | 18,814 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VERNIER CAPITAL PARTNERS, LP | 137,557 | $11,142,000 | 6.62% |
| COMGEST GLOBAL INVESTORS S.A.S. | 637,752 | $51,658,000 | 1.13% |
| Black Creek Investment Management Inc. | 411,525 | $33,334,000 | 1.09% |
| Hillhouse Capital Management | 618,391 | $50,090,000 | 0.88% |
| RUDMAN ERROL M | 21,301 | $1,725,000 | 0.83% |
| JUPITER ASSET MANAGEMENT LTD | 263,705 | $21,360,000 | 0.65% |
| York Capital Management Global Advisors, LLC | 341,616 | $27,671,000 | 0.62% |
| VONTOBEL ASSET MANAGEMENT INC | 873,968 | $71,525,000 | 0.51% |
| Temasek Holdings (Private) Ltd | 990,000 | $80,190,000 | 0.44% |
| WASATCH ADVISORS LP | 292,216 | $23,669,000 | 0.31% |